This study was designed to assess the potential relationship between the late loss of angiographic luminal diameter and biochemical abnormalities of arterial wall collagen in rabbits subjected to angioplasty, and to test the hypothesis that a-aminopropionitrile (#APN), an inhibitor of lysyl oxidase, would inhibit such changes when administered orally for 1 mo after angioplasty. Endovascular injury was induced in rabbit iliac arteries by ipsilateral balloon angioplasty (BA) and by contralateral balloon angioplasty accompanied by exposure to continuous wave neodymium: yttrium aluminum garnet laser radiation (LBA). Computer measurement ofangiographic luminal diameter demonstrated significant vessel narrowing at 1 and 6 mo after both procedures. By quantitative histology, the majority of the 1-mo loss in angiographic diameter could not be attributed to neointimal thickening. Analysis of collagen cross-linking by HPLC in collagen obtained from the LBA-injured segments of the arteries 1 mo after angioplasty revealed a significant increase, relative to values from uninjured arteries (P < 0.05), in the difunctional cross-link dihydroxylysinonorleucine (DHLNL). 6 mo after angioplasty, the content of hydroxpyridinium, the trifunctional maturational product of DHLNL, was significantly elevated in both BA-and LBA-treated arteries compared with values from uninjured arteries (P < 0.05). In animals administered ,fAPN, luminal narrowing at 1 mo, compared with controls, was attenuated (P < 0.01) and DHLNL content was decreased (P < 0.05) in arteries subjected to LBA, but not in arteries subjected to BA. The results suggest that lathyrogenic agents may be efficacious in favorably modulating LBA-induced alterations in vessel diameter and mural connective tissue. (J. Clin. Invest. 1984. 93:1543-1553
Introduction
The pathogenesis of lesion recurrence after initially successful percutaneous transluminal coronary angioplasty and alternative angioplasty procedures is not well defined, but neointimal cellular proliferation and thrombus formation have been im-plicated as components ofnew tissue growth (1) (2) (3) (4) (5) (6) (7) . In addition, production ofextracellular matrix, principally collagen and glycosaminoglycans, within the neointima has been shown to be a prominent feature of the late phase of restenosis lesions, both experimentally and clinically (8) (9) (10) . A less well-recognized hypothesis regarding late luminal compromise is that collagen synthesis may also contribute to intramural fibrosis and possibly to cicatricial contracture after angioplasty injury to all three layers ofthe arterial wall. In the classic wound-healing response observed in other tissues, an increase in the collagen cross-link dihydroxylysinonorleucine (DHLNL)l per mole ofcollagen accompanies biosynthesis of collagen ( 11) and may contribute to stricture formation. However, to our knowledge, no studies have been reported regarding collagen crosslinking as a potential contributory mechanism in the chronic loss in luminal dimensions after angioplasty.
The lathyrogen, j3-aminopropionitrile (,BAPN), is an irreversible inhibitor of lysyl oxidase ( 12) , an extracellular enzyme that promotes crosslink formation in nascent fibrils of both collagen and elastin by conversion of lysine and hydroxylysine side chain residues into aldehydes. Only growing, i.e., newly synthesized collagen fibrils, are rendered lathyrogenic by ,BAPN (13) , and its administration experimentally and clinically as an antifibrotic agent reduces the mechanical strengh of collagen and may enhance collagenolysis (14) (15) (16) (17) . As a result, scar contracture is prevented by f3APN in conditions that would ordinarily be characterized by prominent cross-linking of newly synthesized collagen.
This study was designed to investigate the potential relationship between angioplasty-induced late vessel luminal narrowing and biochemical alterations in arterial wall collagen, and to determine the feasibility of modulating such changes by administration of #3APN. The specific hypotheses tested were:
(a) that the extracellular matrix that accumulates in the arterial wall after angioplasty is structurally abnormal, with cross-linking patterns characteristic of other injury/repair processes known to culminate in deposition of excess collagen; and (b) that inhibition ofabnormal cross-linking ofcollagen by administration of f3APN would reduce the magnitude of late luminal compromise after angioplasty injury in a rabbit model.
Methods Animals
New Zealand White rabbits, weighing 3.5-4.2 kg, were obtained from Harlan Sprague-Dawley (Indianapolis, IN) and subsequently housed and studied in a facility approved by the American Association for the Accreditation of Laboratory Animal Care. In a protocol approved by the Wayne State University Animal Investigation Committee, all animals received humane care in compliance with the "Principles ofLaboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use ofLaboratory Animals" prepared by the National Academy of Sciences (NIH Publication 85- 23, revised 1985) . All rabbits were maintained on standard rabbit chow (Ralston Purina) ad libitum throughout the course of the study.
Rabbits were assigned either to a treatment group (n = 12), which received f3APN fumarate (Sigma) 300 mg/kg orally (dissolved in drinking water) for 1 month after angioplasty or to a control group (n = 18), which did not receive the drug after angioplasty. In addition, five 3.5-4.2-kg rabbits and five 4.2-kg retired breeders, not subjected to angioplasty, served as controls for arterial wall collagen analysis. The quantity of water consumed was examined daily for each rabbit in the treatment group to ensure that the target dose of BAPN was administered.
Angioplasty procedure
Angioplasty was performed bilaterally on the external iliac artery in a manner similar to that described previously (18 to determine mean vessel diameter over a 1-cm axial length of the arterial segment corresponding to the midportion ofthe 2-cm-long balloon. Computer analysis of the inflated balloon, a noncompliant one (polyethylene terephthalate) having a well-defined diameter at 4 bar (either 3.0 or 3.5 mm) used for the angioplasty procedure, was performed to obtain absolute vessel luminal diameter. The accuracy of this extensively validated automated angiographic luminal edge tracking algorithm, developed by us (20) (21) (22) , has been shown to be within 100 um of actual anatomic luminal diameter over a broad range of radiographic conditions.
Quantitative histology
Although the 1-mo mean loss in luminal diameter after either BA or LBA of the external iliac artery of the normocholesterolemic NZW rabbit has been shown (18) to be similar in magnitude to that noted after clinical angioplasty of coronary arteries, the magnitude ofneointimal thickening has not previously been quantitated for this animal model. It should be noted that, in this current study, hypercholesterolemia was not induced primarily for two reasons. Serum cholesterol levels achieved experimentally on a hypercholesterolemic diet typically far exceed those found clinically; in addition, the response in serum cholesterol is heterogeneous, which may increase the variability in the tissue responses to injury, thereby potentially obscuring differences between treatment strategies.
To determine the contribution of neointimal thickening to luminal compromise 1 mo after angioplasty in the normocholesterolemic rabbit model, 1-0 control rabbits, each of which had been subjected to BA and LBA, were killed at this time for quantitative histologic analysis. The segments of external iliac arteries corresponding to the site of angioplasty were removed under fluoroscopic control immediately after a final aortogram and placed in 10% neutral buffered formalin. The segments were not perfused fixed in order to confirm a previously noted effect of laser/thermal exposure on straightening of the elastic lamellae (18) , since a ruffled appearance of the lamellae normally is enhanced without laser/thermal exposure in sections not perfused fixed. After immersion in graded alcohol solutions and embedment in paraffin, microtome sections obtained from the midportion of each specimen were stained with hematoxylin-eosin (H & E), Masson's trichrome, and elastin stains. High quality sections, either H & E-or Masson's trichrome-stained ones, were viewed at X75 with a video camera mounted on a microscope (Reichert-Jung, Buffalo, NY), and video images were digitized by a frame grabber interfaced to a MicroVax II computer. Neointimal and medial areas were automatically determined after manual delineation of the internal and external elastic lamellae and the luminal boundary.
Because of marked retraction and recoil that occurs upon postmortem removal of an arterial section in the rabbit, the histologic luminal area is artifactually much smaller than that in vivo. Therefore, to estimate the contribution of neointimal thickening to the angiographic diameter loss over 1 mo, the luminal area was extrapolated from the angiographic diameter measurement with the assumption of circular symmetry. Neointimal thickness was then estimated as follows: 
Biochemical analyses
Immediately after death at either 1 or 6 mo, iliac artery segments subjected to angioplasty were removed, rinsed in normal saline, and frozen at -70'C until analysis. Additional control rabbits, including five 3.5-kg rabbits and five 5.0-kg retired breeders (representing two different age groups), none of which had been subjected to angioplasty, were killed for similar analysis.
DHLNL and HLNL. DHLNL and HLNL, the major difunctional lysyl oxidase-mediated cross-links in arterial collagen, were reductively labeled as follows: specimens of artery weighing 25-50mg (wet weight) were minced into fine pieces, washed in neutral salt buffer, and reduced with NaB3H4l (42 Ci/Mol; Amersham Corp., Arlington Heights, IL) as described by us in detail previously (23, 24) . The effective reducing capacity of each batch of NaR3H14was determined using b-amino levulinic acid as a standard compound for reduction, thus allowing us to determine molar quantities of cross-links from their radioactivity (24) . Reduced tissues were hydrolyzed in 6 N HOl and hydroxyproline content was determined colorimetrically (25) . Reduced DHLNL and HLNL were analyzed by reverse-phase HPLC under isocratic conditions, using a sodium phosphate-buffered mobile phase containing npropanol and SDS, as described in detail previously (24) . The Table I. after LBA, which was significantly lower than for the other 6 mo after angioplasty, compared with the 1-mo results, three groups (two-way ANOVA, P < 0.01). Similarly, com- there was no change in the mean luminal diameter for the pared with the luminal diameter acutely before angioplasty, the 3APN group for either LBA-or BA-treated arteries, despite diameter at 1 mo was increased by a mean 7% in LBA-treated discontinuation of the drug at 1 mo after the procedure (P arteries in rabbits administered ,3APN, which was significantly > 0.05). It should be noted that no instance ofa late increase in different from the 8-13% mean decrease in this measurement luminal diameter was found (i.e., no evidence of aneurysm in the other three groups (P < 0.01).
formation) in LBA/flAPN-treated arteries in any rabbit. Although a slight acute increase (3%) in luminal diameter was noted after nitroglycerin administration only for BAtreated arteries 1 mo after angioplasty, with or without (3APN, this change was not statistically significant.
Quantitative histology (Fig. 4) Mean neointimal and medial areas of arterial segments from rabbits (n = 10) killed 1 mo after angioplasty were similar for BA and LBA (P > 0.05). The mean diameter losses at 1 mo for this group of rabbits (15 and 19% for BA and LBA, respectively) were similar to those for the entire control group (P > 0.05). When luminal diameter from the angiographic study performed immediately before death at 1 mo was used to extrapolate mean neointimal thickness from the histologic area measurements, mean neointimal thickening was 47 and 20 .m for LBA-and BA-treated arteries, respectively. Mean thickness of the media was found by this approach to be 64 and 55 gm, respectively, for LBA-and BA-treated arteries.
The histologic appearance of the angioplastied arteries was similar between the 1-and 6-mo follow-up periods. The neointima appeared qualitatively similar between BA and LBA at these times, as reported previously (18) . However, as also previously reported, by Masson's trichrome stain, LBA-treated arteries demonstrated a prominent network of collagen in the media, compared with BA-treated arteries (Fig. 5) . Straightening of the internal and external elastic laminae was apparent in LBA-treated arteries, unlike the ruffled appearance of these structures in BA-treated arteries and arteries not subjected to angioplasty.
Biochemical assays (Tables V and VI) DHLNL and HLNL. The reducible cross-links DHLNL and HLNL were readily detectable in arterial collagen. In LBA- values were significantly lower in the older controls (Table VI) as compared with the younger controls ( OHP. OHP was readily detectable in arterial collagen. At 1 mo after angioplasty, there were no differences in OHP content of arterial collagen in either BA-or LBA-treated animals relative to control values. fAPN administration had no effect on OHP content 1 mo after angioplasty. However, 6 mo after angioplasty in the group without 3APN, OHP was significantly elevated relative to controls in both BA-and LBA-treated arteries. As noted above, tissue was not available for biochemical analysis in the ,3APN group at the 6-mo time point.
Discussion
In this present study, we report on structural changes in arterial collagen after endovascular injury, and the effects oflathyrogen administration on such changes. To our knowledge, this is the first report ofthe effects of angioplasty on collagen structure at the molecular level. We hypothesized that the arterial injury induced by angioplasty would result in the classic wound-healing response that has been observed in matrix in many other tissues and organ systems. Initially, there is biosynthesis of collagen characterized by increased content of the difunctional collagen crosslink DHLNL (i.e., an increase in moles of DHLNL/moles of collagen). Collagen content of DHLNL generally returns to normal over time; however, in many types of injury a delayed reponse will occur, characterized by increased collagen content of OHP, the maturational product of DHLNL. This structural abnormality is associated with alterations in the physicochemical properties of collagen, including increased insolubility and stiffness (26, 27) , and is found in various fibrotic disorders characterized by increased deposition of collagen at the site of injury. Recent reviews have described this sterotypical pattern of structural change in collagen in skin, lung, tendon, bone, and cartilage in association with mechanical injury, exposure to various toxins, and certain congenital and acquired diseases (1 1, 26, 28) . In some injury models these may be only barely detectable, and occasionally either the early or late changes may not be apparent at all (29) . A likely reason for such findings is that in some models there is insufficient synthesis of "new," abnormal collagen relative to the normal collagen already present in the given tissue or organ to permit detection of structural changes. Although it is possible to distinguish "new" collagen from "old" collagen in vivo by injecting radiolabeled amino acids at the time ofinjury, such experiments are technically very difficult and subject to much variability (30, 31) . Thus, although our earlier studies of matrix in other models of injury and disease led us to predict a characteristic sequence of changes in vascular collagen after balloon injury, we did not know if such changes would be detectable in vivo. However, in arteries from animals subjected to LBA 1 mo previously, DHLNL content was increased relative to controls as expected. There was no change in OHP at 1 mo, but by 6 mo OHP was significantly increased relative to controls. Although DHLNL decreased significantly in LBA between 1 and 6 mo, DHLNL values were still higher than those of age-matched controls. These findings are consistent with much of our previous work (K. M. Reiser; 26, 28) on the response of matrix biosynthesis to injury and disease. Indeed, the observation that arterial collagen contains increased OHP 6 mo after balloon injury is consistent with histological evidence of excess accumulation of collagen in the arterial wall after endovascular injury. It should be noted that such accumulation of collagen in balloon-injured arteries cannot readily be measured biochemically because the injury site is a segment of an artery, rather than a whole organ. Thus, there is no adequate denominator term to which one can normalize collagen measured biochemically. Such parameters as wet or dry weight, total protein, or cell content may all be affected by the injury, and hence would not serve as reliable denominator terms (32) .
The biochemical changes in BA-treated arteries were not identical to those observed in LBA-treated arteries. Although DHLNL showed no changes by 1 mo after angioplasty, significant increases were observed 6 mo after injury. OHP was also increased 6 mo after injury. In view ofthe marked difference in collagen density noted histologically at follow-up between BAand LBA-treated arteries, both in this study and in previous ones, the possibility exists that the rate of collagen synthesis is slower and/or occurs over a shorter time course after BA than 1550 LBA injury, and the amount of newly synthesized abnormal collagen is insufficient to allow detection of increased levels of DHLNL since there is more normal collagen present relative to newly synthesize collagen. By analogy, we have observed that in models of lung injury the period during which increased DHLNL is detectable may vary depending on the agent used. For example, in lung injury induced by a single intratracheal instillation of bleomycin, DHLNL values are significantly elevated 1 wk after injury, but return to normal by 1 mo (31) . In silica-induced injury, however, DHLNL elevations are readily detectable for several months after injury (33) . Alternatively, laser/thermal exposure may denature collagen, thereby promoting its degradation by proteases to which it would ordinarily be resistant, so that only newly synthesized collagen is available for analysis, while in the BA-treated arteries a mixture of newly synthesized and normal collagen already present is available for analysis. This possibility is supported by recent evidence that laser exposure, at levels ofthermal injury similar to the one used herein, does indeed structurally alter type I collagen by causing widespread denaturation (34) . The crosslink data are consistent with both ofthese hypotheses, in that it appears that newly synthesized collagen containing excess DHLNL is not present in sufficient quantities to permit detection by 1 mo after BA-induced injury, whether because of slower synthesis than in LBA-induced injury, or because ofthe presence of "normal" collagen already present. However, the data clearly show that synthesis ofsuch abnormal collagen does indeed occur after both types ofangioplasty injury, as is evident by increased DHLNL and OHP at 6 mo.
The second major aim of our study was to investigate the effects of ,3APN, a potent inhibitor of lysyl oxidase (12) , on collagen structure after endovascular injury. We found that, for LBA/3APN-treated arteries, DHLNL was significantly decreased 1 mo after angioplasty compared with control LBA arteries, but was still higher than that for arteries not subjected to angioplasty. In contrast, #APN had no significant effect on cross-links in arteries 1 mo after BA, but the DHLNL content ofthe control BA arteries was relatively low as discussed above.
Interestingly, the effects of ,3APN on cross-links were mirrored by the angiographic data (Tables I-IV and Figs. 1-3) . Only arteries subjected to LBA responded to (3APN with reduced luminal narrowing, irrespective of whether the 1-mo luminal diameter was compared with luminal diameter acutely before or after angioplasty; ,BAPN had no significant effect on arteries subjected to BA.
What might be the mechanism of the differential response between the two angioplasty modalities? Given the markedly beneficial response of LBA to JAPN, it is likely that cross-linking of newly synthesized collagen is the predominant mechanism of the usual late loss in diameter of the rabbit iliac artery after this angioplasty modality. That this mechanism would be operative after LBA should not be surprising, in view of the initial inflammatory reaction and late prominent collagen deposition noted experimentally in the media histologically. Although f3APN may inhibit elastin cross-linking (35, 36) , there was no histologic evidence ofincreased elastin content at either 1 or 6 mo after LBA. However, flAPN may alter the cellular response to injury (37, 38) , so that the potential additional effect of other mechanisms cannot be excluded. Considering the observation that the endogenous concentration of monoamine oxidase is relatively high in the rabbit, thereby potentially reducing the effectiveness of f3APN in this species (39, 40) , the response of LBA-treated arteries to this agent may be even more remarkable.
The principle mechanism(s) responsible for the late loss in diameter after BA of the normal rabbit iliac artery is less clear. Neointimal thickening 1 mo after angioplasty was found to contribute to only a minor portion ofthe loss in diameter after either BA or LBA, and medial thickness was found to be similar to that reported by others for the normal rabbit femoral artery (41) . Several groups of investigators have suggested that visco-elastic recoil frequently contributes to luminal compromise after conventional balloon angioplasty (42, 43) . Such recoil appears to be reduced by thermal remodeling ofconnective tissue during LBA, and the straightening ofthe elastic lamellae found at 1 and 6 mo after laser exposure in this and prior studies (18, 44) is consistent with this notion. One would not expect that mechanical recoil after BA is amenable to pharmacologic inhibition. The lack of a significant response of BA treated arteries to a vasodilator at 1 mo after angioplasty makes underlying vasoconstriction an unlikely mechanism for the late loss in luminal diameter. The possibility also exists that a stretch injury of preexisting mature connective tissue contributes to pathologic cross-linking of collagen and/or elastin. If so, thermal denaturation of structural proteins during LBA might inhibit the latter response, and lysyl oxidase inhibitors affect cross-linking only of newly synthesized collagen. Although the response of the injured luminal surface may differ between BA and LBA (45) in terms of platelet deposition, thrombogenicity, rate of reendothelialization, etc., the neointima appeared qualitatively and quantitatively similar between the two modalities, and the contribution of neointimal thickening to the late loss in diameter was minor.
The most important limitation of this study is that the pathogenesis of luminal compromise after angioplasty of atherosclerotic coronary artery lesions clinically is undoubtedly considerably more complex than that responsible for the late loss in diameter in this rabbit model. However, the magnitude of the absolute loss in luminal diameter noted experimentally herein and previously (18) is similar to that reported clinically after both BA (46) and elective LBA (47) . More importantly, use of the model permits examination of the role of potentially important, alternative mechanisms of late luminal compromise independent of overt thrombus formation and prominent neointimal thickening. In addition, prominent intramural fibrosis may characterize some clinical angioplasty procedures other than LBA, e.g., conventional balloon angioplasty that is accompanied by extensive mechanical injury and stent implantation that may produce a foreign body tissue reaction (48) . Additional studies would be required, of course, before extrapolation of the results of the use of,BAPN in conjunction with LBA to other angioplasty modalities.
In summary, our results suggest that the arterial wall is characterized by structural abnormalities of collagen after angioplasty injury, and that the type of angioplasty modality used is a critical variable in influencing matrix biosynthesis. JAPN administration for 1 mo after LBA reduced luminal narrowing for up to 6 mo after the procedure, thus demonstrating the potentially important role of collagen cross-linking and the feasibility of pharmacologic inhibition of the diameter loss. However, whether inhibition of collagen cross-linking would have utility for any angioplasty modality other than LBA is un- 
